A new study raises a red flag about a therapy commonly used in advanced prostate cancer. The work suggests that what's known as androgen deprivation therapy may increase a patient's risk of developing acute kidney injury. The team behind the study says the risk they've identified doesn't outweigh the benefits of the treatment in men who have metastatic prostate cancer. Read more here.
Study mentioned: Lapi F, et al. Androgen Deprivation Therapy and Risk of Acute Kidney Injury in Patients With Prostate Cancer. JAMA. 2013; 310(3):289-296.
No comments:
Post a Comment